Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Tinzaparin on Biomarkers in FIGO Stage III-IV Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy - A Randomized Pilot Study

NCT05284552 is registered in ClinicalTrials.gov with University Hospital, Linkoeping as lead sponsor.

NCT NCT05284552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05284552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Tinzaparin on Biomarkers in FIGO Stage III-IV Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy - A Randomized Pilot Study
Lead sponsor
University Hospital, Linkoeping
Phase
Phase 2
Overall status
Recruiting
Start date
July 12, 2022
Completion date
December 31, 2027
Enrollment
40 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian cancer